Showing 1 - 4 results of 4 for search 'David A Norris', query time: 0.02s
Refine Results
-
1
Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone... by Carl K Edwards, Carl K Edwards, Julie Schwartz Green, Hans-Dieter eVolk, Michael eSchiff, Brian eKotzin, Hiroaki eMitsuya, Tatsuya eKawaguchi, Ken-Mei eSakata, John eCheronis, David eTrollinger, Danute eBankaitis-Davis, Charles A Dinarello, David A Norris, David A Norris, Michael P Bevilacqua, Mayumi eFujita, Mayumi eFujita, Gerd-Rudiger eBermester
Published 2012-12-01
Article -
2
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine by Chiara R. Dart, Nabanita Mukherjee, Carol M. Amato, Anabel Goulding, Morgan MacBeth, Robert Van Gulick, Kasey L. Couts, James R. Lambert, David A. Norris, William A. Robinson, Yiqun G. Shellman
Published 2021-07-01
Article -
3
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade by Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M. Brunetti, Kylie Michel, Kasey L. Couts, Karoline A. Lambert, William A. Robinson, Martin D. McCarter, David A. Norris, Richard P. Tobin, Yiqun G. Shellman
Published 2024-03-01
Article -
4
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma by Nabanita Mukherjee, Carol M. Amato, Jenette Skees, Kaleb J. Todd, Karoline A. Lambert, William A. Robinson, Robert Van Gulick, Ryan M. Weight, Chiara R. Dart, Richard P. Tobin, Martin D. McCarter, Mayumi Fujita, David A. Norris, Yiqun G. Shellman
Published 2020-08-01
Article